NCT05450666 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Moro T, Tinsley G, Bianco A, Marcolin G, Pacelli QF, Battaglia G, Palma A, Gentil P, Neri M, Paoli A
Effects of eight weeks of time-restricted feeding (16/8) on basal metabolism, maximal strength, body composition, inflammation, and cardiovascular risk factors in resistance-trained males. J Transl Med. 2016 Oct 13;14(1):290.
Salles JI, Costa F, Cunha-Cruz V, Cagy M, Piedade R, Ribeiro P
Electrophysiological analysis of the perception of passive movement. Neurosci Lett. 2011 Aug 26;501(2):61-6. doi: 10.1016/j.neulet.2011.05.005. Epub 2011 May 7. Erratum in: Neurosci Lett. 2012 Jun 27;520(1):127. Alves, Heloisa [removed].

Effectiveness of Mobility Exercises in Resistance-Trained Males With Shoulder Immobility in Different Age Groups

Clinical trial NCT05450666 - References